Applies to botulism immune globulin: parenteral powder for iv infusion.

Side effects include:

Erythematous rash.

For Healthcare Professionals

Applies to botulism immune globulin: intravenous powder for injection.

Cardiovascular

Very common (10% or more): Blood pressure increased (75%), pallor (28%), cardiac murmur (15%)

Common (1% to 10%): Tachycardia NOS, peripheral coldness

Postmarketing reports: Cardiac arrest, vascular collapse, hypotension, thromboembolism^[Ref]

Respiratory

Very common (10% or more): Atelectasis (39%), rhonchi (34%), nasal congestion (18%), oxygen saturation decreased (17%), cough (13%), rales (13%), breath sounds decreased (10%)

Common (1% to 10%): Stridor, dyspnea NOS, tachypnea, respiratory arrest

Postmarketing reports: Apnea, acute respiratory distress syndrome, transfusion related acute lung injury, cyanosis, hypoxemia, pulmonary edema, bronchospasm^[Ref]

Gastrointestinal

Very common (10% or more): Dysphagia (65%), loose stools (25%), vomiting (20%), abdominal distension (11%)

Postmarketing reports: Abdominal pain^[Ref]

Dermatologic

Very common (10% or more): Dermatitis contact (24%), rash erythematous (22%)

Postmarketing reports: Stevens-Johnson syndrome, epidermolysis, erythema multiforme, bullous dermatitis^[Ref]

Other

Very common (10% or more): Edema (18%), pyrexia (17%), body temperature decreased (16%)

Postmarketing reports: Rigors^[Ref]

Metabolic

Very common (10% or more): Dehydration (10%)

Common (1% to 10%): Hyponatremia, metabolic acidosis^[Ref]

Immunologic

Very common (10% or more): Otitis media (11%), pneumonia (11%)

Common (1% to 10%): Lower respiratory tract infection, oral candidiasis, urinary tract infection^[Ref]

Local

Common (1% to 10%): Injection site reaction, injection site erythema^[Ref]

Hematologic

Common (1% to 10%): Hemoglobin decreased, anemia

Postmarketing reports: Pancytopenia, leukopenia, hemolysis, positive direct antiglobulin (Coombs) test^[Ref]

Nervous system

Postmarketing reports: Coma, loss of consciousness, seizures, tremor^[Ref]

Hepatic

Postmarketing reports: Hepatic dysfunction^[Ref]

Musculoskeletal

Postmarketing reports: Back pain^[Ref]

Psychiatric

Very common (10% or more): Irritability (41%), agitation (10%)^[Ref]